MOTS‑c (mitochondrial open reading frame of the 12S rRNA type‑c) is a naturally occurring, 16‑amino‑acid peptide encoded by mitochondrial DNA. Dr. Jason Schuster explains that it helps restore mitochondrial function, boosting energy production and overall metabolic health.
A Tiny Mitochondrial Peptide
MOTS‑c stands for mitochondrial open reading frame of the 12S rRNA type‑c. It is a peptide of just 16 amino acids, far smaller than peptides like thymosin β4 (43 amino acids) or thymosin α1 (28 amino acids). Because it is encoded by the mitochondrial genome, it acts directly within the organelle that generates ATP.
- 16 amino acids long
- Encoded by mitochondrial 12S rRNA region
- Smaller than most therapeutic peptides
How MOTS‑c Communicates
Dr. Schuster describes MOTS‑c as a bridge between mitochondrial DNA and nuclear DNA, facilitating endocrine‑like transcriptional regulation of muscle metabolism, insulin response, and energy production. It raises intracellular mitochondrial NAD⁺ levels, which are essential for ATP synthesis, and amplifies the Nrf2 anti‑inflammatory pathway. Exercise naturally spikes MOTS‑c levels by about 12‑fold for roughly four hours, and the peptide can mimic that effect.
- Enhances mitochondrial‑nuclear DNA signaling
- Increases NAD⁺, supporting ATP generation
- Activates Nrf2, a key anti‑inflammatory pathway
- Elevates 12‑fold after exercise for ~4 hours
Why It Matters
According to the video, boosting MOTS‑c improves several aspects of health. It reduces inflammation, improves insulin resistance, and supports cardiovascular health, including protection against myocarditis linked to COVID‑19 vaccination. Better mitochondrial function also translates to more efficient metabolism and potential weight‑loss benefits.
- Decreases systemic inflammation
- Improves insulin sensitivity
- Supports heart and vascular health
- May aid weight management through better metabolism
- Higher levels in young people (≈20 % more) suggest age‑related decline
Practical Use
Dr. Schuster reports that Dr. Edwin Lee uses 10 mg of MOTS‑c subcutaneously once weekly, typically on a rotational schedule of one or two months on followed by an equal off period. An alternative protocol mentioned is a single annual dose of epithalon, though that applies to a different peptide. No serious adverse effects were noted in the discussion.
- 10 mg subcutaneous weekly (Dr. Lee’s protocol)
- Rotational schedule: 1–2 months on, 1–2 months off
- Occasional single‑dose annual use reported for related peptides
- No significant side‑effects reported in the video
“MOTS‑c is essentially a natural, exercise‑mimicking peptide that helps your mitochondria talk to the nucleus and boost energy production.”— Dr. Jason Schuster
Dr. Schuster's short takes on this topic — tap to play.
Go deeper than the summary
Dr. Schuster's accredited courses on supplementation, epigenetics, and peptide therapy — the full research, dosing, and video breakdowns.